Vaping With Diabetes? Here’s What It’s Really Doing to You
Smoking and vaping are widely known to harm your health, but when diabetes is part of the picture, the risks become even more serious.…
This study is for individuals with Type 2 Diabetes and Obesity or Overweight. The purpose of the study is to determine if the study medication is safe and effective in reducing body weight in patients with Type 2 Diabetes. Participants will receive a once-weekly injection of either the study medication (VK2735) or placebo. The study is testing three different doses of the medication: 7.5 mg, 12.5 mg, and 17.5 mg.
To take part in the study, participants should be:
CEO and Medical Director
Director of Clinical Research
Clinical Research Coordinator
Navigator/Study Start-up Manager
Clinical Research Coordinator
Clinical Research Coordinator